Timing of Initiation of LMWH Administration in Pregnant Women With APS
Status:
Completed
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
Evaluation of the effect of altering the timing of initiation of low molecular weight heparin
(LMWH) administration on the pregnancy outcomes in women with antiphospholipid syndrome (APS)